Chemical company Bayer loses appeal against weedkiller cancer ruling | US News | Sky News
Bayer nabs new dealmaker—but after Monsanto, is there enough cash? | Fierce Biotech
Bayer and Johnson & Johnson Settle Lawsuits Over Xarelto, a Blood Thinner, for $775 Million - The New York Times
Critical Mass by Law.com's Amanda Bronstad: In Talc Bankruptcy, Are Trials On the Table? Bayer Wins Big As Roundup Trials Return | Law.com
Bayer vs. Johnson & Johnson: A PR Overview - PR News
Johnson & Johnson and Bayer Settle 25,000 Xarelto Lawsuits for $775M
Dan Johnson - Lead Medical Science Liaison - Bayer | LinkedIn
Erick Johnson - System Software Verification & Validation Engineer - Bayer Pharmaceuticals | LinkedIn
Bayer, J&J pay $775M to settle 25,000 Xarelto lawsuits | Fox Business
Johnson & Johnson and Bayer to pay $775M to settle Xarelto suits - New York Business Journal
Johnson & Johnson and Bayer Slammed with First Xarelto Loss, Ordered to Pay $28 Million | Mesothelioma Law Firm
Lawyers Accuse J&J and Bayer of Withholding Xarelto Study Data
FDA inspection found problems at factory making Johnson and Johnson vaccine | MPR News
Bayer lifted by likely new trial in $289 million glyphosate case | The Western Producer
Evolution of Retail & Commerce: Johnson & Johnson, Bayer & Kroger Featured Panel - YouTube
Bayer loses Johnson appeal | Farm Online | ACT
Bayer vs Johnson & Johnson | Comparably
